BE894185A - PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE - Google Patents

PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE

Info

Publication number
BE894185A
BE894185A BE6/47701A BE6047701A BE894185A BE 894185 A BE894185 A BE 894185A BE 6/47701 A BE6/47701 A BE 6/47701A BE 6047701 A BE6047701 A BE 6047701A BE 894185 A BE894185 A BE 894185A
Authority
BE
Belgium
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
BE6/47701A
Other languages
French (fr)
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE894185A publication Critical patent/BE894185A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE6/47701A 1981-08-27 1982-08-24 PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE BE894185A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
BE894185A true BE894185A (en) 1983-02-24

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47701A BE894185A (en) 1981-08-27 1982-08-24 PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE

Country Status (20)

Country Link
JP (1) JPS5846024A (en)
AU (1) AU551879B2 (en)
BE (1) BE894185A (en)
CA (1) CA1176158A (en)
CH (1) CH650679A5 (en)
DE (1) DE3232034A1 (en)
DZ (1) DZ452A1 (en)
FR (1) FR2513126B1 (en)
GB (1) GB2104382B (en)
IE (1) IE54119B1 (en)
IL (1) IL66611A0 (en)
IT (1) IT1153182B (en)
LU (1) LU84359A1 (en)
MW (1) MW3882A1 (en)
NL (1) NL192192C (en)
NZ (1) NZ201682A (en)
PH (1) PH19361A (en)
SE (1) SE460334B (en)
ZA (1) ZA826159B (en)
ZW (1) ZW17482A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
JPH01501389A (en) * 1986-10-20 1989-05-18 ノボ インダストリ アクティーゼルスカブ polypeptide formulation
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
WO1988006599A1 (en) * 1987-02-25 1988-09-07 Novo Industri A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
ATE63821T1 (en) * 1987-08-14 1991-06-15 Akzo Nv MEDICATION FOR PREVENTING OR COMBATING COMPLICATIONS OF DIABETES.
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (en) * 2004-11-22 2011-01-19 诺和诺德公司 Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
EP2571896A4 (en) 2010-05-17 2014-01-08 Cebix Inc Pegylated c-peptide
WO2013075117A2 (en) 2011-11-17 2013-05-23 John Wahren Pegylated c-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
LU84359A1 (en) 1983-02-28
CH650679A5 (en) 1985-08-15
CA1176158A (en) 1984-10-16
IT1153182B (en) 1987-01-14
IE54119B1 (en) 1989-06-21
AU8759482A (en) 1983-03-03
DE3232034A1 (en) 1983-03-10
MW3882A1 (en) 1984-07-11
FR2513126A1 (en) 1983-03-25
NL192192B (en) 1996-11-01
PH19361A (en) 1986-04-02
DZ452A1 (en) 2004-09-13
ZA826159B (en) 1984-04-25
NL8203315A (en) 1983-03-16
SE8204873D0 (en) 1982-08-25
SE8204873L (en) 1983-02-28
IE822064L (en) 1983-02-27
IL66611A0 (en) 1982-12-31
NZ201682A (en) 1985-08-16
DE3232034C2 (en) 1991-04-11
ZW17482A1 (en) 1982-11-17
AU551879B2 (en) 1986-05-15
FR2513126B1 (en) 1986-04-18
NL192192C (en) 1997-03-04
GB2104382A (en) 1983-03-09
SE460334B (en) 1989-10-02
IT8223017A0 (en) 1982-08-27
JPS5846024A (en) 1983-03-17
GB2104382B (en) 1984-12-19

Similar Documents

Publication Publication Date Title
PT78732B (en) 13-ALPHA-ALKYLGONANEES THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
FR2513126B1 (en) PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN AND HUMAN C-PEPTIDE
BE894188A (en) PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN AND HUMAN PROINSULIN
IT8324035A0 (en) CEFEM COMPOUNDS WITH PHARMACEUTICAL ACTIVITY AND PROCEDURES FOR THEIR PREPARATION.
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
BE894187A (en) PHARMACEUTICAL FORMULATIONS COMPRISING HUMAN INSULIN A HUMAN C-PEPTIDE AND HUMAN PROINSULIN
FR2511866B1 (en) PHARMACEUTICAL FORMULATIONS OF HUMAN PROINSULIN
IT1165553B (en) PHARMACEUTICAL COMPOSITION WITH ANTIATEROSCLEROTIC ACTIVITY AND PROCEDURE FOR ITS PREPARATION
IT8420759A1 (en) COMPOSITION WITH IMPROVED PHARMACEUTICAL ACTIVITY AND ITS USE FOR VETERINARY USES
IT1157306B (en) VACCINE AGAINST HUMAN BRUCELLOSIS AND PROCEDURE FOR ITS PREPARATION
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
BE885510A (en) OMNI-POTENT MEDICINE FOR MULTIPLE SCLEROSIS AND ARTERIO-SCLEROSIS THERAPEUTICS
JO1236B1 (en) pharmaceutical formulations comprising human insulin and human c-peptide

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 20020824